$SBRA
Sabra Health Care REIT, Inc.

2011 Q4 Form 10-Q Financial Statement

#000149229811000025 Filed on November 03, 2011

View on sec.gov

Income Statement

Concept 2011 Q4 2011 Q3
Revenue $26.30M $21.47M
YoY Change 199.03%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.200M $4.700M
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.400M $6.850M
YoY Change 136.12%
% of Gross Profit
Operating Expenses $11.60M $11.50M
YoY Change
Operating Profit
YoY Change
Interest Expense -$7.600M -$7.600M
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $7.200M $2.300M
YoY Change 2791.57%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $7.200M $2.344M
YoY Change 102757.14%
Net Earnings / Revenue 27.38% 10.92%
Basic Earnings Per Share $0.07
Diluted Earnings Per Share $193.5K $0.07
COMMON SHARES
Basic Shares Outstanding 36.87M shares 32.99M shares
Diluted Shares Outstanding 33.05M shares

Balance Sheet

Concept 2011 Q4 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.30M $56.40M
YoY Change -42.99% -13.23%
Cash & Equivalents $42.25M $56.42M
Short-Term Investments
Other Short-Term Assets $17.10M $19.80M
YoY Change 42.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $59.40M $76.20M
YoY Change -89.55% -86.18%
LONG-TERM ASSETS
Property, Plant & Equipment $653.4M $649.3M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $36.90M $32.60M
YoY Change 19.03% 3522.22%
Total Long-Term Assets $690.3M $681.8M
YoY Change 2417.05% 6393.76%
TOTAL ASSETS
Total Short-Term Assets $59.40M $76.20M
Total Long-Term Assets $690.3M $681.8M
Total Assets $749.7M $758.0M
YoY Change 25.8% 34.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.10M $17.60M
YoY Change 51.61%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $39.60M $43.90M
YoY Change 11.24% 4777.78%
LONG-TERM LIABILITIES
Long-Term Debt $378.9M $384.2M
YoY Change -1.94% -0.77%
Other Long-Term Liabilities $4.500M
YoY Change
Total Long-Term Liabilities $383.4M $384.2M
YoY Change -0.78% -12.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $39.60M $43.90M
Total Long-Term Liabilities $383.4M $384.2M
Total Liabilities $423.1M $428.1M
YoY Change 1.04% -2.77%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $369.0K $369.0K
YoY Change 47.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $326.6M $329.9M
YoY Change
Total Liabilities & Shareholders Equity $749.7M $758.0M
YoY Change 25.8% 34.96%

Cashflow Statement

Concept 2011 Q4 2011 Q3
OPERATING ACTIVITIES
Net Income $7.200M $2.344M
YoY Change 102757.14%
Depreciation, Depletion And Amortization $7.400M $6.850M
YoY Change 136.12%
Cash From Operating Activities $10.20M $16.60M
YoY Change 54.73%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$11.50M -$113.7M
YoY Change -117.14%
Cash From Investing Activities -$11.50M -$113.7M
YoY Change -117.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.90M 150.1M
YoY Change -2566.54%
NET CHANGE
Cash From Operating Activities 10.20M 16.60M
Cash From Investing Activities -11.50M -113.7M
Cash From Financing Activities -12.90M 150.1M
Net Change In Cash -14.20M 53.00M
YoY Change -119.13%
FREE CASH FLOW
Cash From Operating Activities $10.20M $16.60M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2010Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
9286000 USD
CY2011Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
17641000 USD
CY2010Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
-7000 USD
CY2011Q3 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
14193000 USD
CY2011Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
343748000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56417000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17816000 USD
CY2010Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
177275000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3249000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-11000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1507000 USD
CY2010Q4 us-gaap Assets
Assets
599559000 USD
CY2011Q3 us-gaap Assets
Assets
758045000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74233000 USD
CY2011Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2010Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.32
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.64
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.64
CY2010Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2011Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25061072 shares
CY2011Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36868248 shares
CY2010Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25061072 shares
CY2011Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36868248 shares
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
251000 USD
CY2011Q3 us-gaap Common Stock Value
CommonStockValue
369000 USD
CY2011Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
26300000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
26300000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19227000 USD
CY2011Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6850000 USD
us-gaap Dividends Common Stock
DividendsCommonStock
-19878000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2011Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4652000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10245000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7860000 USD
us-gaap Increase Decrease In Deferred Rent Receivables
IncreaseDecreaseInDeferredRentReceivables
720000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-556000 USD
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
2837000 USD
CY2011Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
7624000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
22726000 USD
CY2011Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
21294000 USD
us-gaap Interest Paid
InterestPaid
17024000 USD
CY2010Q4 us-gaap Liabilities
Liabilities
422026000 USD
CY2011Q3 us-gaap Liabilities
Liabilities
428121000 USD
CY2011Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
758045000 USD
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
599559000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
140809000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-193134000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34509000 USD
us-gaap Net Income Loss
NetIncomeLoss
5678000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
2344000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
57483000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
19878000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
495000 USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
86000 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
5348000 USD
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
187700000 USD
CY2010Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2010Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2010Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2010Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2010Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
163431000 USD
CY2010Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
88701 USD
CY2011Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
107887 USD
CY2011Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
649251000 USD
CY2010Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
482297000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2249000 USD
CY2011Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6286000 USD
CY2010Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4716000 USD
CY2011Q3 us-gaap Revenues
Revenues
21470000 USD
us-gaap Revenues
Revenues
57876000 USD
CY2011Q3 us-gaap Secured Debt
SecuredDebt
159180000 USD
CY2010Q4 us-gaap Secured Debt
SecuredDebt
161440000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3249000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
163342000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
177533000 USD
CY2011Q3 us-gaap Stockholders Equity
StockholdersEquity
329924000 USD
CY2010Q4 us-gaap Unsecured Debt
UnsecuredDebt
225000000 USD
CY2011Q3 us-gaap Unsecured Debt
UnsecuredDebt
225000000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27891690 shares
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33049621 shares
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32986657 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27797411 shares
sbra Interest Income
InterestIncome
393000 USD
CY2011Q3 sbra Interest Income
InterestIncome
176000 USD
CY2011Q3 sbra Liability For Uncertain Tax Positions
LiabilityForUncertainTaxPositions
26300000 USD
CY2010Q4 sbra Liability For Uncertain Tax Positions
LiabilityForUncertainTaxPositions
26300000 USD
CY2010Q4 sbra Prepaid Expenses Deferred Financing Costs And Other Assets
PrepaidExpensesDeferredFinancingCostsAndOtherAssets
12013000 USD
CY2011Q3 sbra Prepaid Expenses Deferred Financing Costs And Other Assets
PrepaidExpensesDeferredFinancingCostsAndOtherAssets
19791000 USD
CY2011Q3 sbra Total Expenses
TotalExpenses
19126000 USD
sbra Total Expenses
TotalExpenses
52198000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
dei Document Period End Date
DocumentPeriodEndDate
2011-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001492298
CY2011Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36868248 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Sabra Health Care REIT, Inc.

Files In Submission

Name View Source Status
0001492298-11-000025-index-headers.html Edgar Link pending
0001492298-11-000025-index.html Edgar Link pending
0001492298-11-000025.txt Edgar Link pending
0001492298-11-000025-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sbra-20110930.xml Edgar Link completed
sbra-20110930.xsd Edgar Link pending
sbra-20110930_cal.xml Edgar Link unprocessable
sbra-20110930_def.xml Edgar Link unprocessable
sbra-20110930_lab.xml Edgar Link unprocessable
sbra-20110930_pre.xml Edgar Link unprocessable
sbra10q093011.htm Edgar Link pending
sbraex121093011.htm Edgar Link pending
sbraex311093011.htm Edgar Link pending
sbraex312093011.htm Edgar Link pending
sbraex321093011.htm Edgar Link pending
sbraex322093011.htm Edgar Link pending
Show.js Edgar Link pending